SETH LERNER, MD
Urology at Fannin St, Houston, TX

License number
Texas G8900
Category
Radiology
Type
Urology
Address
Address
6560 Fannin St, Houston, TX 77030
Phone
(713) 798-4001
(713) 798-6005 (Fax)

Personal information

See more information about SETH LERNER at radaris.com
Name
Address
Phone
Seth Lerner, age 67
6520 Buffalo Speedway, Houston, TX 77005
Seth P Lerner, age 67
6520 Buffalo Speedway, Houston, TX 77001
(713) 432-1577
(713) 798-4001
Seth Lerner, age 67
6520 Butala Spdwy, Houston, TX 77005
(713) 432-1577
Seth P Lerner
6560 Fannin St #2100, Houston, TX 77030
(713) 798-4001
Seth P Lerner, age 67
7622 Northwoods Dr, Sugar Land, TX 77479
(281) 937-0372

Organization information

See more information about SETH LERNER at bizstanding.com

Seth Lerner MD,FACS

6620 Main St, Houston, TX 77030

Industry:
Surgeons, Internist, Urologist
Phone:
(713) 798-4001 (Phone)
Seth Paul Lerner

Professional information

See more information about SETH LERNER at trustoria.com
Seth Lerner Photo 1
Professor Of Urology At Baylor College Of Medicine

Professor Of Urology At Baylor College Of Medicine

Position:
Professor of Urology at Baylor College of Medicine
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
Baylor College of Medicine - Professor of Urology


Seth P Lerner Photo 2
Seth P Lerner, Houston TX

Seth P Lerner, Houston TX

Specialties:
Urologist
Address:
6560 Fannin St, Houston, TX 77030
6620 Main St, Houston, TX 77030
5445 La Branch St, Houston, TX 77004
Board certifications:
American Board of Urology Certification in Urology*


Seth Lerner Photo 3
Methods To Determine Prognosis After Therapy For Bladder Cancer

Methods To Determine Prognosis After Therapy For Bladder Cancer

US Patent:
2003003, Feb 13, 2003
Filed:
May 24, 2002
Appl. No.:
10/156667
Inventors:
Kevin Slawin - Houston TX, US
Shahrokh Shariat - Dallas TX, US
Seth Lerner - Houston TX, US
International Classification:
G01N033/574
US Classification:
435/007230
Abstract:
A method to diagnose, stage and predict prognosis of bladder cancer patients is provided, e.g., using TGF-1, IL-6, IL-6sR, uPA, uPAR and IGFBP-3. These markers, and potentially others, in combination with standard clinical and pathologic features, may be used to create a nomogram that would be useful for managing bladder cancer patients.